Dishi Wang

435 citations
12 papers · 364 indexed · h-index 9
Co-authors
Xinru LiYanxia ZhouLei ZhaoJinwen LiYan LiuYajie GaoChao ZhangDietmar Appelhans
Topics
Nanoparticle-Based Drug Delivery (5 papers)Supramolecular Self-Assembly in Materials (5 papers)Lipid Membrane Structure and Behavior (3 papers)
Partner nations
GermanyChinaSwitzerland

In The Last Decade

Dishi Wang

12 papers receiving 362 citations

Peers

Dishi Wang
Comparison fields: 5 of 69
  • Biomaterials 210
  • Molecular Biology 150
  • Biomedical Engineering 118
  • Organic Chemistry 84
  • Polymers and Plastics 45
Replace Wei‐Hsin Hsu with:
Wei‐Hsin Hsu Taiwan
Ankit Gangrade India
Joshua Seaberg United States
Marta Kumorek Czechia
Endiries Yibru Hanurry Taiwan
Lingjie Ke China
Tefera Worku Mekonnen Taiwan
Sarah S. Kermaniyan Australia
Fabiola Porta Switzerland
Dishi Wang relative to Wei‐Hsin Hsu Taiwan Wei‐Hsin Hsu's profile →
Citations per field
00.5×1.5×2.5×
Wei‐Hsin Hsu · 1×
Citations per year

Countries citing papers authored by Dishi Wang

Since Specialization
Citations

This map shows the geographic impact of Dishi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dishi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dishi Wang more than expected).

Fields of papers citing papers by Dishi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dishi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dishi Wang. The network helps show where Dishi Wang may publish in the future.

Co-authorship network of co-authors of Dishi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dishi Wang. A scholar is included among the top collaborators of Dishi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dishi Wang. Dishi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 3
2 2
3 4
4 20
5 18
6 23
7 16
8 54
9 47
10 46
11 86
12 45

About Dishi Wang

Dishi Wang is a scholar working on Biomaterials, Toxicology and Pharmaceutical Science, having authored 12 papers that have together received 364 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Supramolecular Self-Assembly in Materials (5 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Biomaterials (210 citations), Pharmaceutical Science (30 citations) and Molecular Medicine (22 citations). Dishi Wang has collaborated with scholars based in Germany, China and Switzerland. Frequent co-authors include Xinru Li, Yanxia Zhou, Lei Zhao, Jinwen Li, Yan Liu, Yajie Gao, Chao Zhang, Dietmar Appelhans, Ziqi Wang and Sílvia Moreno. Their work appears in journals such as Nature Communications, Advanced Functional Materials and Chemical Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026